Request for Free Sample

Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Radioisotope Type

  2.3.2 Market Size By Service Type

  2.3.3 Market Size By Application

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

 4.1 Pricing Analysis & Forecast

  4.1.1 Overview

  4.1.2 Pricing Analysis & Forecast By Radioisotope Type, 2022–2035

  4.1.3 Pricing Analysis & Forecast By Service Type, 2025–2035

         4.1.4 Pricing Analysis & Forecast By Application, 2025–2035

 4.2 Regulatory & Compliance Analysis

  4.2.1 Overview

  4.2.2 Nuclear Regulatory Framework Assessment

  4.2.3 GMP Compliance Landscape

         4.2.4 Radiopharmaceutical Manufacturing Standards

 4.3 Technology Adoption Analysis

  4.3.1 Overview

  4.3.2 Automated Radiochemistry Systems

  4.3.3 Advanced Hot Cell Infrastructure

  4.3.4 Theranostic Manufacturing Technologies

5. Radiopharmaceutical CDMO Market Segmental Analysis & Forecast, By Radioisotope Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Lutetium-177 (Lu-177)

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Gallium-68 (Ga-68)

     5.4 Fluorine-18 (F-18)

     5.5 Actinium-225 (Ac-225)

     5.6 Others

6. Radiopharmaceutical CDMO Market Segmental Analysis & Forecast, By Service Type, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Process Development

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Analytical & QC Testing

     6.4 Clinical Manufacturing

     6.5 Commercial Manufacturing

     6.6 Fill-Finish & Packaging

7. Radiopharmaceutical CDMO Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Oncology

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Cardiology

     7.4 Neurology

     7.5 Theranostics

     7.6 Others

8. Radiopharmaceutical CDMO Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Pharmaceutical Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Biotechnology Companies

     8.4 Academic & Research Institutes

     8.5 Nuclear Medicine Centers

     8.6 Hospitals & Health Systems

9. Radiopharmaceutical CDMO Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Radiopharmaceutical CDMO Market Size & Forecast, By Radioisotope Type, 2022–2035

 9.2.3 Radiopharmaceutical CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.2.4 Radiopharmaceutical CDMO Market Size & Forecast, By Application, 2022–2035

 9.2.5 Radiopharmaceutical CDMO Market Size & Forecast, By End User, 2022–2035

 9.2.6 Radiopharmaceutical CDMO Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Radiopharmaceutical CDMO Market Size & Forecast, By Radioisotope Type, 2022–2035

 9.3.3 Radiopharmaceutical CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.3.4 Radiopharmaceutical CDMO Market Size & Forecast, By Application, 2022–2035

 9.3.5 Radiopharmaceutical CDMO Market Size & Forecast, By End User, 2022–2035

 9.3.6 Radiopharmaceutical CDMO Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Radiopharmaceutical CDMO Market Size & Forecast, By Radioisotope Type, 2022–2035

 9.4.3 Radiopharmaceutical CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.4.4 Radiopharmaceutical CDMO Market Size & Forecast, By Application, 2022–2035

 9.4.5 Radiopharmaceutical CDMO Market Size & Forecast, By End User, 2022–2035

 9.4.6 Radiopharmaceutical CDMO Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Radiopharmaceutical CDMO Market Size & Forecast, By Radioisotope Type, 2022–2035

 9.5.3 Radiopharmaceutical CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.5.4 Radiopharmaceutical CDMO Market Size & Forecast, By Application, 2022–2035

 9.5.5 Radiopharmaceutical CDMO Market Size & Forecast, By End User, 2022–2035

 9.5.6 Radiopharmaceutical CDMO Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Radiopharmaceutical CDMO Market Size & Forecast, By Radioisotope Type, 2022–2035

 9.6.3 Radiopharmaceutical CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.6.4 Radiopharmaceutical CDMO Market Size & Forecast, By Application, 2022–2035

 9.6.5 Radiopharmaceutical CDMO Market Size & Forecast, By End User, 2022–2035

 9.6.6 Radiopharmaceutical CDMO Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Radioisotope Type/Service & Service Application Benchmarking

  10.4.1 Radioisotope Type/Service Specifications & Features By Key Players

  10.4.2 Radioisotope Type/Service Heatmap By Key Players

  10.4.3 Service Type Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Curium

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Radioisotope Type/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

  10.6.2 Eckert & Ziegler

      10.6.3 ITM Isotope Technologies Munich SE

      10.6.4 NorthStar Medical Radioisotopes

      10.6.5 Cardinal Health

      10.6.6 SOFIE Biosciences

      10.6.7 PharmaLogic Holdings Corp.

      10.6.8 SpectronRx

       10.6.9 Monrol

      10.6.10 SHINE Technologies

      10.6.11 IONETIX Corporation

      10.6.12 Nucleus RadioPharma

     10.6.13 Evergreen Theragnostics

     10.6.14 Minerva Imaging

     10.6.15 Seibersdorf Labor GmbH

     10.6.16 Nihon Medi-Physics Co., Ltd.

     10.6.17 Advanced Accelerator Applications

     10.6.18 Jubilant Radiopharma

     10.6.19 Telix Pharmaceuticals

     10.6.20 Isotopia Molecular Imaging

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures